ALX ONCOLOGY HOLDINGS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

ALXO

organization

SIC: 2834

SEC Insider

$134.6M

429 transactions

Summary

ALX ONCOLOGY HOLDINGS INC (ALXO) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $91.8MSales: $41.8M39 insiders

Date	Insider	Type	Value
2026-02-02	GOODMAN COREY S	Buy	$5.0M
2026-03-19	Lettmann Jason(CHIEF EXECUTIVE OFFICER)	Sell	$27K
2026-02-17	Lettmann Jason(CHIEF EXECUTIVE OFFICER)	F	$5K
2026-01-06	Pinto Shelly(SVP, FINANCE AND CAO)	Sell	$4K
2026-03-19	Pinto Shelly(SVP, FINANCE AND CAO)	Sell	$2K
2026-02-18	Pinto Shelly(SVP, FINANCE AND CAO)	Sell	$1K
2026-04-16	Klencke Barbara(Chief Medical Officer)	A	$0
2026-04-16	Knight Jeff E.(Chief Dev & Operating Officer)	A	$0
2026-03-03	Klencke Barbara(Chief Medical Officer)	A	$0
2026-01-26	Lettmann Jason(CHIEF EXECUTIVE OFFICER)	A	$0
2026-01-26	Pinto Shelly(SVP, FINANCE AND CAO)	A	$0
2026-01-26	Shantharam Harish(Chief Financial Officer)	A	$0
2026-01-20	Hemrajani Rekha	A	$0
2026-01-20	Takimoto Chris H	A	$0
2026-01-20	Curran Daniel J.	A	$0
2026-01-20	Sandler Alan B.	A	$0
2026-01-20	Garland J. Scott	A	$0
2026-01-20	GOODMAN COREY S	A	$0
2025-10-14	Shantharam Harish(Chief Financial Officer)	A	$0
2025-10-14	Lettmann Jason(CHIEF EXECUTIVE OFFICER)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ALX ONCOLOGY HOLDINGS INC — Contributions, Lobbying & Contracts | Poliscope